why choose us

First received: March 28, 2023

Clinical Trial: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Alzheimer's Disease

Study Type: INTERVENTIONAL


Official Title: A Phase IIa, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 50561 in Patients With Mild or Mod

Brief Summary: This is a multi-center, Phase IIa, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy, safety of two doses of 50561 compared to placebo in participants diagnosed with mild to moderate Alzheimer's disease.

Read more